Clinical trial
Personalized Circulating DNA Follow-up in Melanoma
NCT04866680 is registered in ClinicalTrials.gov with Institut de Cancérologie de Lorraine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Circulating DNA Follow-up in Melanoma
- Lead sponsor
- Institut de Cancérologie de Lorraine
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 31, 2023
- Completion date
- November 30, 2028
- Enrollment
- 136 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.